DUBLIN--(BUSINESS WIRE)--Aug 3, 2018--The "Global Opioids Market - Segmented by Product Type, Application, Receptor-binding, Application, and Geography - Growth, Trends, and Forecast (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.

The global opioids market is expected to register a CAGR of nearly 5.0 % during the forecast period, 2018-2023.

The rising prevalence of orthopedic disorders, such as arthritis, elbow pain, fibromyalgia, and osteoporosis, coupled with the associated chronic pain, are the primary factors responsible for the growth of the opioids market. Opioids play a vital role in the acute post-operative settings, to provide adequate analgesia. As per the Center for Disease Control and Prevention, over 30 million patients are affected by osteoarthritis each year, in the United States.

The increased prescription of opioid medications has led to the widespread misuse of both prescription and non-prescription opioids, which leads to its highly addictive nature. According to the US Department of Health and Human Services, in 2016, more than 11 million people misused the prescription opioids, including nearly two million who misused the prescription drug for the first time. The Canadian Institute of Health Information reported that in 2016, there were more than 2,800 opioid-related deaths in the country.

Due to rising adoption of opioids and growing geriatric population, particularly in the United States, North America is expected to dominate the market studied. The country is affected by the over-consumption of prescription and over-the-counter opioids. A large section of the US population indicates an increased dependence over oxycodone, hydrocodone, and morphine, which are being commonly prescribed to treat pain.

Companies Mentioned

Allergan Egalet Corporation Endo Pharmaceuticals Inc. Janssen Pharmaceuticals Inc. Mallinckrodt Pfizer Inc. Purdue Pharma LP Qrxpharma Limited Sun Pharmaceutical Industries Ltd Teva Pharmaceutical Industries Ltd

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

7. Market Segmentation

8. Competitive Landscape

9. Key Players

10. Future of the Market

For more information about this report visit https://www.researchandmarkets.com/research/mj8hj5/global_opioids?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180803005343/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Analgesics

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/03/2018 10:42 AM/DISC: 08/03/2018 10:41 AM

http://www.businesswire.com/news/home/20180803005343/en